ArticleDementia and geriatric cognitive disorders extra

Efficacy, Safety, and Tolerability of Switching from Oral Cholinesterase Inhibitors to Rivastigmine Transdermal Patch with 1-Step Titration in Patients with Mild to Moderate Alzheimer's Disease: A 24-Week, Open-Label, Multicenter Study in Japan.

Kengo Ueda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.